Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Cole-Carpenter syndrome in which the cause of the disease is a mutation in the P4HB gene.
Features include always present findings: Sideways curvature of the spine (scoliosis), Short stature, Coronal craniosynostosis, and Popcorn calcification and others; and common findings: Dentinogenesis imperfecta, Frontal bossing, Wormian bones, and Micrognathia. 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 6 | Sideways curvature of the spine (scoliosis), Mild bone density loss (osteopenia), Recurrent fractures |
P4HB encodes prolyl 4-hydroxylase subunit beta (508 aa). This multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. Highest expression in Cells Cultured fibroblasts (1,253 TPM) and Pancreas (960.6 TPM).
Cole-Carpenter syndrome 1 is associated with mutations in the P4HB gene on chromosome 17.
The P4HB protein participates in ERO1B oxidizes P4HB, GPX7,8 catalyze peroxidation of P4HB (PDI), and P4HB mediates disulfide bond formation in Proinsulin pathways.
P4HB is classified as a druggable target (Druggable Genome, Enzyme, External Side Of Plasma Membrane, and Thioredoxin categories) with score 4.0.
Genetic testing for P4HB is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 11 always present features, 4 common features.
No clinical trials have been registered for Cole-Carpenter syndrome 1.
5 publications have been identified in PubMed for Cole-Carpenter syndrome 1. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (40%), and Case Report / Case Series (20%).
Lu Y (2025). [PMID: 40065084](https://pubmed.ncbi.nlm.nih.gov/40065084/). *Commun Biol*. [Basic Science / Preclinical]
Xu S (2025). [PMID: 39778777](https://pubmed.ncbi.nlm.nih.gov/39778777/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Ryhänen EM (2025). [PMID: 41128774](https://pubmed.ncbi.nlm.nih.gov/41128774/). *J Bone Miner Res*. [Case Report / Case Series]
Cotti S (2025). [PMID: 41410595](https://pubmed.ncbi.nlm.nih.gov/41410595/). *Clin Sci (Lond)*. [Review / Meta-Analysis]
Sillence DO (2024). [PMID: 38942908](https://pubmed.ncbi.nlm.nih.gov/38942908/). *Calcif Tissue Int*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Oct 4, 2026, 3:02 AM UTC
Online Mendelian Inheritance in Man
Common questions about Cole-Carpenter syndrome 1
Brain and nerves | 3 | Global developmental delay, Hydrocephalus, Communicating hydrocephalus |
Head and neck | 2 | Coronal craniosynostosis, Orbital craniosynostosis |
Growth and development | 1 | Short stature |